Eli Lilly is just weeks away from launching ... which was approved by the MHRA last year, the Mounjaro KwikPen can be used to treat adults with type 2 diabetes and for weight management in adult ...

Eli Lilly applied for HSE reimbursement of Mounjaro for diabetes treatment more than one year ago The ... Tirzepatide is administered subcutaneously once-weekly and is delivered in a ‘KwikPen’, a ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast Eli Lilly ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss drug in India by 2025 after regulatory approvals, reported News18 citing officials from ...

Eli Lilly reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but saw lower realized prices. Demand in the U.S. has far outpaced supply ...